Brandon Capital

Portfolio Co Investors 2026 for Brandon Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Brandon Capital accounts for 9 tracked companies with verified cap-table data, 9 of which disclose round sizes totalling $991M. The median disclosed raise is $70M, and the largest is AdvanCell at $440M, ahead of Myricx Bio ($114M) and NRG Therapeutics ($86M).

The names that recur most often on these co-invested cap tables are Brandon Capital (9 companies), Abingworth (3 companies), Omega Funds (2 companies), Novartis Venture Fund (2 companies), Forbion (2 companies), Ally Bridge Group (1 company). By latest disclosed round, the market skews Series D (3), Series A (3), Series B (3).

Best funded Brandon Capital companies

  1. AdvanCell — $440M (latest: Series D)
  2. Myricx Bio — $114M (latest: Series A)
  3. NRG Therapeutics — $86M (latest: Series B)
  4. Entact Bio — $81M (latest: Series A)
  5. Tizona Therapeutics — $70M (latest: Series D)
  6. Pheon Therapeutics — $68M (latest: Series A)
  7. Interventional Pain Management — $58M (latest: Series D)
  8. Aravax — $42M (latest: Series B)
  9. Ena Respiratory — $33M (latest: Series B)

Brandon Capital — related firms and companies (52)

Brandon Capital profile · All research reports